Rock Over Medicine AB
ActiveKey figures
Key figures
2025Summary: Rock Over Medicine AB
What kind of company is it?
Rock Over Medicine AB (org. no. 559293-2015) is a limited company (AB). The company was registered in 2020 and has existed for 5 years. Registered seat: Göteborg. Industry according to Statistics Sweden: general primary medical practice activities (SNI 86211).
How is the company doing financially?
Net sales in financial year 2025 were −1 kr. Net profit for 2025 was 502 kr. The company was profitable in all 5 reported financial years. According to the annual report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 461 802 kr and equity 314 886 kr (equity ratio 68,2 %). The annual report for 2025 proposes a dividend of 36 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 36 000 kr.
Summary of annual reports2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 863 261 | 940 638 | 188 160 | 0 | −1 |
| Profit for the reporting year | 306 261 | 423 168 | 91 286 | 30 670 | 502 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 517 374 | 889 972 | 717 720 | 569 146 | 461 802 |
| Total liabilities | 186 113 | 435 543 | 384 006 | 204 762 | 146 916 |
| Total equity | 331 261 | 454 429 | 333 714 | 364 384 | 314 886 |
| Employees | 1 | 1 | 1 | — | 0 |
| Proposed dividend | 250 000 | 266 000 | 150 000 | 50 000 | 36 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.